dapsone has been researched along with Urticaria in 40 studies
Urticaria: A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The appearance of bite cells associated with methemoglobinemia can be caused by oxidizing drugs such as dapsone in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency or high drug serum levels." | 8.12 | Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria. ( Awan, M; Brown, LE; Gandelman, JS; Geere, M; Hu, Y; Kogan, SC; Leavitt, AD; Pearson, HJ, 2022) |
| " Improvement in CSU was observed in 62 patients (78%) (36 [80%] with idiopathic and 26 [76%] with autoimmune disease) with dapsone." | 7.91 | Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria. ( Hoffmann, R; Liang, SE; Peterson, E; Soter, NA, 2019) |
| " With adequate monitoring, the use of dapsone in patients with pressure urticaria has such a good risk-benefit ratio that we support early treatment initiation." | 7.77 | Delayed pressure urticaria - dapsone heading for first-line therapy? ( Brehler, R; Grundmann, SA; Kiefer, S; Luger, TA, 2011) |
| "Dapsone (4,4'-diaminodiphenyl sulphone) is used for a variety of dermatological conditions including immunobullous diseases and urticarial vasculitis." | 7.72 | A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. ( Barker, TH; Gaffney, K; Garioch, JJ; Leslie, KS; Ridley, S; Ross, CN, 2003) |
| " We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone." | 7.68 | Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990) |
| "Dapsone 100 mg daily led to a rapid and complete clearing of extensive vasculitic urticarial lesions in a female patient with systemic lupus erythematosus." | 7.66 | Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. ( Goerz, G; Ruzicka, T, 1981) |
| "A cases of systemic lupus erythematosus is reported, presenting with urticaria-like lesions and complement deficiencies, which was completely controlled by dapsone." | 7.66 | Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone. ( Matthews, CN; Saihan, EM; Warin, RP, 1978) |
| " The following drugs are undoubtedly effective and sometimes even the therapy of choice: tetracyclines in acne vulgaris and rosacea (including rosacea keratitis); penicillin G in acrodermatitis atrophicans and cold urticaria; dapsone in dermatitis herpetiformis and - as a powerful adjuvant - in acne vulgaris and rosacea." | 4.76 | [Positive side-effects of antibiotic and antimicrobial drugs in therapy (author's transl)]. ( Illig, L, 1979) |
| "The appearance of bite cells associated with methemoglobinemia can be caused by oxidizing drugs such as dapsone in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency or high drug serum levels." | 4.12 | Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria. ( Awan, M; Brown, LE; Gandelman, JS; Geere, M; Hu, Y; Kogan, SC; Leavitt, AD; Pearson, HJ, 2022) |
| " Improvement in CSU was observed in 62 patients (78%) (36 [80%] with idiopathic and 26 [76%] with autoimmune disease) with dapsone." | 3.91 | Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria. ( Hoffmann, R; Liang, SE; Peterson, E; Soter, NA, 2019) |
| " With adequate monitoring, the use of dapsone in patients with pressure urticaria has such a good risk-benefit ratio that we support early treatment initiation." | 3.77 | Delayed pressure urticaria - dapsone heading for first-line therapy? ( Brehler, R; Grundmann, SA; Kiefer, S; Luger, TA, 2011) |
| "Dapsone (4,4'-diaminodiphenyl sulphone) is used for a variety of dermatological conditions including immunobullous diseases and urticarial vasculitis." | 3.72 | A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. ( Barker, TH; Gaffney, K; Garioch, JJ; Leslie, KS; Ridley, S; Ross, CN, 2003) |
| " We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone." | 3.68 | Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990) |
| "Dapsone 100 mg daily led to a rapid and complete clearing of extensive vasculitic urticarial lesions in a female patient with systemic lupus erythematosus." | 3.66 | Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. ( Goerz, G; Ruzicka, T, 1981) |
| "A cases of systemic lupus erythematosus is reported, presenting with urticaria-like lesions and complement deficiencies, which was completely controlled by dapsone." | 3.66 | Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone. ( Matthews, CN; Saihan, EM; Warin, RP, 1978) |
| "The first line treatment of urticaria still consists of non-sedating H1-antihistamines." | 2.42 | [New therapeutic strategies for the different subtypes of urticaria]. ( Kapp, A; Liekenbröcker, T; Raap, U; Wedi, B; Wieczorek, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (25.00) | 18.7374 |
| 1990's | 6 (15.00) | 18.2507 |
| 2000's | 9 (22.50) | 29.6817 |
| 2010's | 12 (30.00) | 24.3611 |
| 2020's | 3 (7.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnekoh, H | 1 |
| Jelden-Thurm, J | 1 |
| Butze, M | 1 |
| Krause, K | 1 |
| Maurer, M | 1 |
| Kolkhir, P | 1 |
| Hu, Y | 3 |
| Geere, M | 3 |
| Awan, M | 3 |
| Leavitt, AD | 3 |
| Brown, LE | 3 |
| Pearson, HJ | 3 |
| Gandelman, JS | 3 |
| Kogan, SC | 3 |
| Zheng, BQ | 1 |
| Yan, YL | 1 |
| Ou, M | 1 |
| Wang, XH | 1 |
| Holm, JG | 1 |
| Ivyanskiy, I | 1 |
| Thomsen, SF | 1 |
| Takenaka, Y | 1 |
| Ishiguro, N | 1 |
| Kawashima, M | 1 |
| Gusdorf, L | 1 |
| Lipsker, D | 1 |
| Cortés-Pinto, C | 1 |
| Baradad Brusau, M | 1 |
| Vilardell Vilellas, F | 1 |
| Mascaró Galy, JM | 1 |
| Arco Huguet, N | 1 |
| Soria Gili, X | 1 |
| Liang, SE | 1 |
| Hoffmann, R | 1 |
| Peterson, E | 1 |
| Soter, NA | 1 |
| Christiansen, J | 1 |
| Kahn, R | 1 |
| Schmidtchen, A | 1 |
| Berggård, K | 1 |
| Nath, PI | 1 |
| Coop, CA | 1 |
| Milkova, L | 1 |
| Hallermann, C | 1 |
| Simon, JC | 1 |
| Treudler, R | 1 |
| Seminario-Vidal, L | 1 |
| Sami, N | 1 |
| Miller, J | 1 |
| Theos, A | 1 |
| do Valle, SO | 1 |
| França, AT | 1 |
| Pires, GV | 1 |
| Guimarães, P | 1 |
| Dias, GA | 1 |
| Levy, SA | 1 |
| Grundmann, SA | 1 |
| Kiefer, S | 1 |
| Luger, TA | 1 |
| Brehler, R | 1 |
| Noda, S | 1 |
| Asano, Y | 1 |
| Sato, S | 1 |
| Leslie, KS | 1 |
| Gaffney, K | 1 |
| Ross, CN | 1 |
| Ridley, S | 1 |
| Barker, TH | 1 |
| Garioch, JJ | 1 |
| Harthi, FA | 1 |
| Kudwah, A | 1 |
| Ajlan, A | 1 |
| Nuaim, A | 1 |
| Shehri, F | 1 |
| Raap, U | 1 |
| Liekenbröcker, T | 1 |
| Wieczorek, D | 2 |
| Kapp, A | 1 |
| Wedi, B | 1 |
| Cassano, N | 1 |
| D'Argento, V | 1 |
| Filotico, R | 1 |
| Vena, GA | 1 |
| Lee, JS | 1 |
| Loh, TH | 1 |
| Seow, SC | 1 |
| Tan, SH | 1 |
| Engin, B | 1 |
| Ozdemir, M | 1 |
| Criado, RF | 1 |
| Criado, PR | 1 |
| Martins, JE | 1 |
| Valente, NY | 1 |
| Michalany, NS | 1 |
| Vasconcellos, C | 1 |
| Parodi, A | 1 |
| Nunzi, E | 1 |
| Rebora, A | 1 |
| Ruzicka, T | 1 |
| Goerz, G | 1 |
| Highet, AS | 1 |
| Nürnberg, W | 1 |
| Grabbe, J | 1 |
| Czarnetzki, BM | 1 |
| Valsecchi, R | 1 |
| Rozzoni, M | 1 |
| Sena, P | 1 |
| Pansera, B | 1 |
| Eiser, AR | 1 |
| Singh, P | 1 |
| Shanies, HM | 1 |
| Boehm, I | 1 |
| Bauer, R | 1 |
| Bieber, T | 1 |
| Cadnapaphornchai, MA | 1 |
| Saulsbury, FT | 1 |
| Norwood, VF | 1 |
| Illig, L | 1 |
| Matthews, CN | 1 |
| Saihan, EM | 1 |
| Warin, RP | 1 |
| González Quijada, S | 1 |
| López Lázaro, L | 1 |
| Reinares García, L | 1 |
| Borregón Carretero, SJ | 1 |
| Sastre Varela, J | 1 |
| Estrada Pérez, V | 1 |
| Holtman, JH | 1 |
| Neustadt, DH | 1 |
| Klein, J | 1 |
| Callen, JP | 1 |
| Faulhaber, G | 1 |
| Lechner, W | 1 |
| Wozel, G | 1 |
| Thiele, B | 1 |
| Fortson, JS | 1 |
| Zone, JJ | 1 |
| Hammond, ME | 1 |
| Groggel, GC | 1 |
| Frucht, U | 1 |
| Gramm, HJ | 1 |
| Dennhardt, R | 1 |
| Muramatsu, C | 1 |
| Tanabe, E | 1 |
4 reviews available for dapsone and Urticaria
| Article | Year |
|---|---|
Use of nonbiologic treatments in antihistamine-refractory chronic urticaria: a review of published evidence.
Topics: Anti-Allergic Agents; Chronic Disease; Cyclosporine; Dapsone; Databases, Factual; Drug Resistance; H | 2018 |
Neutrophilic urticarial dermatosis: A review.
Topics: Arthralgia; Colchicine; Cryopyrin-Associated Periodic Syndromes; Dapsone; Dermis; Diagnosis, Differe | 2018 |
[New therapeutic strategies for the different subtypes of urticaria].
Topics: Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Autoimmunity; | 2004 |
[Positive side-effects of antibiotic and antimicrobial drugs in therapy (author's transl)].
Topics: Acne Vulgaris; Acrodermatitis; Adolescent; Anti-Bacterial Agents; Child; Dapsone; Dermatitis Herpeti | 1979 |
3 trials available for dapsone and Urticaria
| Article | Year |
|---|---|
Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone | 2005 |
Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria.
Topics: Adolescent; Adult; Case-Control Studies; Dapsone; Female; Folic Acid Antagonists; Histamine H1 Antag | 2008 |
Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features.
Topics: Acetates; Adult; Anti-Infective Agents; Chronic Disease; Colchicine; Cyclopropanes; Dapsone; Drug Th | 2008 |
33 other studies available for dapsone and Urticaria
| Article | Year |
|---|---|
In Urticarial Vasculitis, Long Disease Duration, High Symptom Burden, and High Need for Therapy Are Linked to Low Patient-Reported Quality of Life.
Topics: Adult; Colchicine; Dapsone; Female; Humans; Male; Middle Aged; Omalizumab; Patient Reported Outcome | 2022 |
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur | 2022 |
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur | 2022 |
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur | 2022 |
Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria.
Topics: Dapsone; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Ur | 2022 |
Successful treatment of acquired cutis laxa with urticarial eruption by diphenyl sulfone.
Topics: Adult; Cutis Laxa; Dapsone; Dermatologic Agents; Drug Administration Schedule; Female; Humans; Urtic | 2021 |
Case of acquired cutis laxa with preceding urticarial eruption treated by diphenyl sulfone.
Topics: Adult; Anetoderma; Dapsone; Female; Humans; Skin; Treatment Outcome; Urticaria | 2018 |
Bullous pemphigoid in a 3-month-old infant after vaccination.
Topics: Anti-Infective Agents; Autoantibodies; Blister; Dapsone; Humans; Infant; Male; Pemphigoid, Bullous; | 2019 |
Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Chronic Disea | 2019 |
Idiopathic angioedema and urticarial vasculitis in a patient with a history of acquired haemophilia.
Topics: Aged; Angioedema; Autoimmunity; Azathioprine; Colchicine; Dapsone; Drug Therapy, Combination; Hemoph | 2015 |
Rash and a patch test result positive for cobalt in a patient with a hip replacement.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Cetirizine; Cobalt; Dapsone | 2014 |
Asymptomatic dapsone-induced agranulocytosis in a patient with chronic spontaneous urticaria.
Topics: Aged; Agranulocytosis; Chronic Disease; Dapsone; Dose-Response Relationship, Drug; Granulocyte Colon | 2014 |
Mycophenolate mofetil therapy for pediatric bullous pemphigoid.
Topics: Anti-Bacterial Agents; Clindamycin; Dapsone; Diagnosis, Differential; Drug Resistance; Humans; Immun | 2015 |
Dapsone hypersensitivity syndrome during delayed pressure urticaria treatment.
Topics: Adult; Dapsone; Dengue; Diagnosis, Differential; Drug Hypersensitivity; Erythema; Female; Fever; His | 2010 |
Delayed pressure urticaria - dapsone heading for first-line therapy?
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ascorbic Acid; Chronic Disease; Dapsone; Dose | 2011 |
Long-term complete resolution of severe chronic idiopathic urticaria after dapsone treatment.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Female; Humans; Middle Aged; Neut | 2012 |
A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Hypersensitivity; Female; Humans; Middle Aged | 2003 |
Urticaria-like follicular mucinosis responding to dapsone.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Face; Humans; Mucinosis, Follicular; Urticaria | 2003 |
[Treating chronic urticaria].
Topics: Adrenal Cortex Hormones; Adult; Child; Chloroquine; Chronic Disease; Cyclosporine; Dapsone; Diagnosi | 2006 |
Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; Blood Vessels; Colchicine; Daps | 2007 |
Urticaria as presenting manifestation of pemphigus herpetiformis.
Topics: Administration, Topical; Adult; Aminopyrine; Anti-Inflammatory Agents; Dapsone; Female; Humans; Midd | 1982 |
Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels.
Topics: Adult; Complement System Proteins; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Urticaria | 1981 |
Urticarial vasculitis resembling systemic lupus erythematosus: efficacy of prednisone and dapsone combined.
Topics: Adult; Dapsone; Diagnosis, Differential; Humans; Lupus Erythematosus, Systemic; Male; Prednisone; Ur | 1980 |
Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline.
Topics: Adult; Antigen-Antibody Complex; Complement C3; Dapsone; Drug Combinations; Drug Resistance; Female; | 1995 |
Cold urticaria and delayed pressure urticaria in the same patient.
Topics: Anti-Allergic Agents; Cold Temperature; Cyproheptadine; Dapsone; Female; Folic Acid Antagonists; Hum | 1996 |
Sustained dapsone-induced remission of hypocomplementemic urticarial vasculitis--a case report.
Topics: Adult; Dapsone; Female; Humans; Skin; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous | 1997 |
Urticaria treated with dapsone.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Humans; Male; Urticaria | 1999 |
Hypocomplementemic urticarial vasculitis: report of a pediatric case.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Child; Complement System Proteins; Dapsone; Fema | 2000 |
Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone.
Topics: Complement System Proteins; Dapsone; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Urt | 1978 |
[Gastrointestinal involvement and the response to dapsone in a case of the urticarial vasculitis syndrome].
Topics: Adult; Chronic Disease; Dapsone; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Human | 1991 |
Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
Topics: Administration, Oral; Adult; Complement C2; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneous; | 1990 |
[Urticaria-vasculitis with bullous eruptions in visceral lupus erythematosus].
Topics: Adult; Antigen-Antibody Complex; Biopsy; Dapsone; Drug Therapy, Combination; Female; Fluorescent Ant | 1987 |
[Urticaria vasculitis and sulfone, a case report].
Topics: Aged; Dapsone; Female; Humans; Urticaria; Vasculitis, Leukocytoclastic, Cutaneous | 1987 |
Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone.
Topics: Arthritis; Complement System Proteins; Dapsone; Female; Glomerulonephritis; Humans; Kidney Glomerulu | 1986 |
[Toxic methemoglobinemia following the postoperative ingestion of 4,4-diaminodiphenylsulfone (DADPS)--on the differential diagnosis of cyanosis].
Topics: Adult; Cyanosis; Dapsone; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Me | 1985 |
Urticarial vasculitis: response to dapsone and colchicine.
Topics: Colchicine; Dapsone; Female; Humans; Middle Aged; Urticaria; Vasculitis | 1985 |